Maureen Ohlhausen

Maureen K. Ohlhausen chairs Baker Botts’ Global Antitrust and Competition practice. Her practice focuses on antitrust, privacy and data security and consumer protection investigations and litigation both in the U.S. and abroad. Ms. Ohlhausen joined the firm after leading the Federal Trade Commission as Acting Chairman and Commissioner. She directed all aspects of the FTC’s antitrust work, including merger review and conduct enforcement, and steered all FTC consumer protection enforcement, with a particular emphasis on privacy and technology issues. A thought leader, Ms. Ohlhausen has published dozens of articles on antitrust, privacy, IP, regulation, FTC litigation, telecommunications, and international law issues in prestigious publications and has testified over a dozen times before the U.S. Congress.

Ms. Ohlhausen has relationships with officials in the U.S. and abroad, with a particular emphasis on Europe and China, and has led the U.S. delegation at international antitrust and data privacy meetings on many occasions. She has received numerous awards, including the FTC’s Robert Pitofsky Lifetime Achievement Award.  Prior to her role as Commissioner, Ms. Ohlhausen led the FTC’s Internet Access Task Force, which produced an influential report analyzing competition and consumer protection legal issues in the areas of broadband and Internet.

In private practice, she headed the FTC practice group at a leading telecommunications firm, representing and counseling telecommunications and technology clients on antitrust compliance, privacy, and consumer protection matters before the FTC and the FCC. She also clerked at the U.S. Court of Appeals for the D.C. Circuit.

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More

U.S. Universities: Engines of Economic Growth

By Sujai Shivakumar, Charles Wessner, Chris Borges, and Shruti Sharma Universities are among the United States’ most enduring sources of competitive advantage and a key pillar of the nation’s innovation system. Home to more than 35 of the world’s top 100 research universities, the United States owes many of its most
Read More